Anika Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Anika Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Anika Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 15.1M shares, a 1.77% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 15.1M +262K +1.77% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 15.1M +264K +1.78% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 15M +268K +1.82% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 14.8M +223K +1.53% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 14.8M +218K +1.49% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 14.8M +218K +1.49% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 14.7M +223K +1.54% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 14.6M +184K +1.27% Dec 31, 2022 10-K 2024-03-15
Q3 2022 14.6M +171K +1.19% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 14.6M +180K +1.25% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 14.5M +152K +1.06% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 14.4M +112K +0.78% Dec 31, 2021 10-K 2023-03-16
Q3 2021 14.4M +228K +1.61% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 14.4M +214K +1.51% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 14.4M +168K +1.18% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 14.3M +21K +0.15% Dec 31, 2020 10-K 2022-03-11
Q3 2020 14.2M -61K -0.43% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 14.2M +419K +3.04% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 14.2M -16K -0.11% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 14.3M +98K +0.69% Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 14.3M +58K +0.41% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 13.8M -799K -5.48% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 14.2M -531K -3.6% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 14.2M -478K -3.25% Dec 31, 2018 10-K 2020-03-06
Q3 2018 14.2M -451K -3.08% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 14.6M -74K -0.51% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 14.7M +90K +0.61% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 14.7M +61K +0.42% Dec 31, 2017 10-K 2019-02-27
Q3 2017 14.7M +39K +0.27% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 14.7M -120K -0.81% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 14.7M -113K -0.77% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 14.6M -410K -2.73% Dec 31, 2016 10-K 2018-02-27
Q3 2016 14.6M -389K -2.59% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 14.8M -226K -1.51% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 14.8M -235K -1.57% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 15M +185K +1.25% Dec 31, 2015 10-K 2017-02-24
Q3 2015 15M +211K +1.43% Sep 30, 2015 10-Q 2015-11-03
Q2 2015 15M +206K +1.39% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 15M +383K +2.62% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 14.9M +562K +3.94% Dec 31, 2014 10-K 2016-03-10
Q3 2014 14.8M +534K +3.75% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 14.8M +781K +5.57% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 14.6M +614K +4.38% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 14.3M +423K +3.05% Dec 31, 2013 10-K 2015-03-13
Q3 2013 14.3M +461K +3.34% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 14M +251K +1.83% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 14M +243K +1.77% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 13.9M +235K +1.73% Dec 31, 2012 10-K 2014-03-13
Q3 2012 13.8M +183K +1.34% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 13.8M +144K +1.06% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 13.8M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 13.6M +148K +1.1% Dec 31, 2011 10-K 2013-03-14
Q3 2011 13.6M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 13.6M Jun 30, 2011 10-Q/A 2011-08-10
Q4 2010 13.5M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.